Homepage
Author:
Tivic Health Systems
Posted Date:
March 31, 2026
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod
Tivic Health Systems
March 31, 2026
Tivic CEO To Present at the Upcoming Emerging Growth’s April 2026 Virtual Conference
Tivic Health Systems
March 27, 2026
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome
Tivic Health Systems
March 26, 2026
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
Tivic Health Systems
March 20, 2026
Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma
Tivic Health Systems
March 4, 2026
Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10
Tivic Health Systems
February 18, 2026
Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting
Tivic Health Systems
January 28, 2026
